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 1 
Abstract – Chemical investigation of the culture broth of the fungus Eutypella scoparia ICB-
OBX, isolated from the marine pulmonate mollusc Onchidium sp., led to the finding of novel 
compounds 1 and 2, structurally related to angiotensin II binding inhibitors cytosporins, along 
with unrelated known nitrogen metabolites (compounds 3-5). The structure and the relative 
stereochemistry of the novel metabolites were assigned mainly by a detailed analysis of two-
dimensional NMR techniques whereas the absolute stereochemistry was proposed by 
modified Mosher’s method. Compound 2 contains an unusual cyclic carbonate functionality 
that is rare among natural products. 
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1. Introduction 
Marine micro-organisms such as bacteria and fungi inhabit every environment of the 
sea and are rich sources of pharmacologically active compounds.
1
 The interest towards 
marine micro-organisms has grown in the last years due to the possibility to get abundant 
biomass by in vitro culturing and consequently large amount of produced secondary 
metabolites. Among marine micro-organisms, fungi have shown great potential due to the 
high structural diversity of natural products biosynthesized.
2
 The majority of the chemical 
data reported in the literature refer to fungi derived from sponges and algae whereas only a 
few papers deal with the secondary metabolites of mollusc-derived fungi.
2,3
 In particular, an 
unique gastropod mollusc, the sea hare Aplysia kurodai, has been reported as source of fungal 
isolates producing compounds with antitumor and cell adhesion inhibition activities.
4
 
In the course of our investigation on marine molluscs
5
 we analysed the pulmonate 
gastropod Onchidium sp., collected in the intertidal area of Hainan (South China Sea), that 
was found to be characterised by a series of unprecedented polypropionates.
6
 Subsequently 
we also examined the secondary metabolites produced in the culture broth of the fungus 
Eutypella scoparia ICB-OBX, which was isolated from the external part of the mollusc. This 
study led to two novel molecules 1 and 2, along with known nitrogen compounds 3-5, 
previously reported from fungi and natural sources.
7,8
 Compounds 1 and 2 are structurally 
 2 
related to cytosporins A-C, isolated from an endophytic strain of the taxonomically related 
fungus Cytospora and showed to be angiotensin II binding inhibitors.
9
 
In this paper, the chemical characterization of the new metabolites that we named cytosporin 
D (1) and cytosporin E (2) is described. 
 
2. Results and Discussion 
The EtOAc extract of the culture broth was analyzed by TLC chromatography by using 
different eluent systems. The secondary metabolite pattern was found to be dominated by the 
presence of a main spot at Rf 0.6 (CHCl3/CH3OH, 95:5) along with a series of minor 
components. The extract was purified by silica-gel column chromatography 
(chloroform/methanol gradient) to give two main fractions containing the compounds of 
interest. The two fractions were further purified by silica-gel column (n-hexane/EtOAc 
gradient) to obtain compounds 1 (5.1 mg) and 2 (9.0 mg), along with the main metabolite 
phenochalasin B (3, 28.3 mg), from the more polar fraction, whereas cyclo-(D)-Pro-(D)-Leu 
(4, 3.9 mg) and cyclo-(D)-Pro-(D)-Phe (5, 2.0 mg) were recovered from the less polar 
fraction. 
The already known compounds 3-5 were identified by comparing their spectral data (
1
H and 
13
C NMR, MS and []D) with the literature.
7,8 
The new molecules 1 and 2 were characterized 
as below described. 
Cytosporin D (1) showed the molecular formula C19H30O5 as deduced by the sodiated-
molecular peak at m/z 361.1988 in the HR-ESIMS spectrum indicating five degrees of 
unsaturation. The 
13
C-NMR spectrum disclosed seven sp
3
 carbons between  57.4 and  77.7 
that were assigned to carbons linked to oxygen (one primary, four secondary and two 
tertiary), eight sp
3
 high-field resonating signals between  14.3 and 36.5, and four sp2 
carbons at 126.7 (d, C-14), 130.7 (s, C-8), 133.5 (s, C-9), and 135.7 (d, C-15) indicating 
two double bonds. The remaining unsaturations required by the formula were thus attributed 
to three rings. The 
1
H-NMR spectrum showed two olefinic signals at  6.48 (H-14) and 6.15 
(H-15), which were attributed to the protons of a disubstituted double bond, four methines 
and a methylene linked to oxygenated carbons at  4.65 (H-7), 4.53 (H-10), 4.41 (H-13a), 
4.08 (H-13b), 3.68 (H-3) and 3.29 (H-6), two methyl singlets at  1.30 (H3-11) and 1.25 (H3-
 3 
12), and a methyl triplet at  0.95 (H3-20). A series of multiplet signals due to five 
methylenes completed the spectrum (Table 1). Analysis of 
1
H-
1
H COSY spectrum clearly 
defined some spin systems (Fig. 1): the chain C-14/C-20 ( 6.48, d, (15.8), H-14;  6.15, dt, 
(7.0, 15.8), H-15;  2.23, td, (7.0), H2-16;  1.50, m, H2-17;  1.40, m, H2-18;  1.38, m, H2-
19 and  0.95, t, (6.6), H3-20, fragment a), an isolated oxygenated methylene ( 4.41, d, 
(12.0), H-13a and  4.08, d, (12.0), H-13b, fragment b), two vicinal oxygenated methines ( 
4.65, br s, H-7 and  3.29, br s, H-6, fragment c), and an ABX system constituted by a 
methylene linked a carbinolic proton ( 2.32, t, (12.0), H-4ax,  1.70, dd, (4.8, 12.0), H-4eq 
and  3.68,dd, (4.8, 12.0), H-3, fragment d). Long-range experiments aided us to link these 
partial structures. In particular, the signal at  77.7 (C-2) had diagnostic correlations with the 
methyls at  1.30 (H3-11) and 1.25 (H3-12) and with the protons at  3.68 (H-3) and  4.53 
(H-10). The signal at  57.4 (C-5) had cross-peaks with the protons at  3.29 (H-6),  4.65 
(H-7), and the methylene at  2.32 and 1.70 (H2-4) whereas the signal at  133.5 (C-9) 
showed correlations with methines at  4.53 (H-10),  4.65 (H-7), and  6.15 (H-15), as well 
as with the isolated methylene at  4.41 and 4.08 (H2-13). These data were consistent with a 
tricyclic structure containing an hexahydrobenzopyrane moiety fused with an oxirane ring as 
reported in formula 1. To confirm the suggested gross structure, a sample of compound 1 was 
acetylated by Ac2O/DMPA in CH2Cl2 leading to the triacetyl derivative 1a, which was 
analysed by 
1
H-NMR. Diagnostic acylation shifts were observed for H-3, H-7 and H2-13 (see 
Experimental Section) in agreement with the proposed structure. Compound 1 exhibits a 
carbon skeleton characterized by a polyketide moiety and a terpenoid part, reported only 
previously for cytosporins A-C e.g. cytosporin C (6), which were isolated some years ago 
from an endophytic Cytospora sp.
9
 The full structure characterization of cytosporins A-C has 
never been published whereas their pharmacological properties in the inhibition of 
angiotensin II binding have been described.
9,10
 The structure proposed for compound 6
9
 
displayed strong analogies with compound 1 differing only in the length of the reduced chain 
at C-8 and in the presence of the aldehyde function at C-9 replacing of the hydroxyl 
methylene group. However, the unassigned 
13
C-NMR data reported for 6 match almost 
completely with those of compound 1. Our tentative assignment (see Experimental Section) 
 4 
displayed the main difference for the C-7 carbon value. This anomaly could be justified by a 
different orientation of the hydroxy group at C-7 that was not determined for cytosporin C 
(6).  
The relative stereochemistry of cytosporin D (1) was only partially defined by NMR analysis. 
The hydroxyl at C-3 was equatorial as inferred by the multiplicity of the carbinolic proton H-
3 (dd, J=12.0 and 4.8 Hz) consistently with an axial orientation. A diagnostic NOE effect was 
observed between H-10 ( 4.53) and the axial methyl H3-11 ( 1.30;  16.4, C-11) supporting 
the axial orientation of H-10. The other steric effects observed in a series of NOE difference 
experiments were not useful to establish the orientation of both the epoxide ring at C-5/C-6 
and the hydroxyl group at C-7 of cytosporin-D (1) that remained undetermined. Further data 
were obtained by analysis of the spectral data of the co-occurring cytosporin-E (2). 
The molecular formula of compound 2 was C20H30O7 as deduced from the sodiated peak at 
m/z 405.1883 in the HRESIMS spectrum, implying six degrees of unsaturation and an 
additional CO2 unit with respect to 1. The 
1
H-NMR spectrum of 2 showed strong analogies 
with that of cytosporin-D (1) (Table 1) indicating the presence of the same 
hexahydrobenzopyrane skeleton with an alkyl chain at C-8. In particular, the major 
differences were observed for H-6 and H-7 protons resonating in compound 2 at  4.78 (dd, 
J=7.9 and 1.7 Hz) and  5.58 (d, J=7.9 Hz), respectively, whereas in compound 1 these 
signals resonated at  3.29 (br s) and  4.65 (br s) (Table 1). This was consistent with a 
different substitution pattern in this part of the molecule. The presence of a carbonate moiety 
in compound 2 was suggested by a strong IR absorption at 1650 cm
-1
 as well as by a 
diagnostic 
13
C NMR signal at 156.0. The 13C-NMR spectrum of 2 showed in addition the 
expected four sp
2
 carbons, seven sp
3
 carbons linked to oxygen and eight sp
3
 high-field 
resonating signals, similar to those of 1, accounting for 20 carbons as required by mass 
formula (Table 1). 
The 
1
H-
1
H COSY spectrum of 2 revealed the presence of the same spin systems as 1 (partial 
structures a-d, Fig. 1), that were connected by HMBC analysis to give the same carbon 
framework. In particular, diagnostic HMBC correlations between C-21 ( 156.0) and both 
protons H-6 ( 4.78) and H-7 ( 5.58) led us to link the carbonyl to both oxygen atoms at C-6 
and C-7 obtaining a cyclic carbonate moiety, as reported in formula 2. Such functionality, 
 5 
which is quite rare in nature, has been reported for metabolites [e.g. phomoxin C (7)] of fungi 
of genera Phoma
11 
and Eupenicillium.
12
 
A sample of compound 2 was submitted to acetylation giving the diacetate derivative 2a, 
which was characterized by 
1
H NMR and mass spectroscopy. Diagnostic acylation shifts were 
observed for H-3 and H2-13 (see Experimental Section) in agreement with the proposed 
structure.  
The relative stereochemistry of cytosporin-E (2) was determined by analysis of both 
1
H-
1
H 
coupling constants and n.O.e. difference experiments. Analogously with 1, the multiplicity of 
the carbinolic proton H-3 ( 4.05, dd, J=11.8 and 4.8 Hz) indicated the equatorial orientation 
of the hydroxyl group at C-3 whereas significant n.O.e. interactions between H-10 ( 4.25) 
and the axial methyl H3-11 ( 1.30) supported the axial orientation of H-10. The cis-junction 
of the hexahydrobenzopyrane moiety of cytosporin-E (2) was determined by analysing a 
NOESY experiment carried out on the acetyl derivative 2a, with the tertiary –OH being the 
unique hydroxyl group free. A clear cross peak between H-10 ( 4.25) and OH-5 ( 5.60) was 
observed in the spectrum recorded in DMSO-d6 (see Experimental Section) thus inferring the 
same orientation of the angular substituents at C-5 and C-10. Finally, the irradiation of H-6 ( 
4.78) caused the enhancement of both H-7 ( 5.58) and H-4eq ( 2.30) signals indicating that 
the carbonate cycle was trans-oriented with respect to the angular OH-5. Accordingly, a 
strong n.O.e. effect was observed between H-15 ( 6.08) and H-7 ( 5.58). 
Once the relative stereochemistry of cytosporin-E (2) was established, a possible correlation 
between the two co-occurring cytosporins was evaluated. From a biogenetic point of view, 
compound 2 could be considered as derived from compound 1. In fact, it should be formed by 
the attack of a carbonate ion at C-6 of the oxirane ring of compound 1 by the less-hindered 
face. The esterification of the carbonate unit by the vicinal hydroxyl at C-7 should give the 
closure of the ring leading to cytosporin-E (2). This implies that the relative stereochemistry 
at C-5, C-6 and C-7 of cytosporin-D (1) should be that reported, with the 5,10 cis-junction 
and the hydroxyl group at C-7 trans-oriented with respect to the oxirane ring. 
Finally, the absolute stereochemistry of cytosporins was determined by applying the modified 
Mosher’s method13 on more stable cytosporin-D (1). After protection of the primary hydroxyl 
group at C-13 with DMT (See Experimental Section), 1b was reacted with (-)-R- and (+)-S-
 6 
MTPA chlorides to obtain S-ester (1c) and R-ester (1d), respectively. The  values (S – R) 
observed for the signals of protons nearby the hydroxyl group at C-3 and C-7 (see Table 2) 
indicated the S and the R configuration respectively, as reported in formula. 
Cytosporin-D (1) and -E (2) were tested in antimicrobial assays against S. aureus, E. coli and 
C. albicans. No inhibitory activity was observed for the two molecules. 
In conclusion, two new molecules have been isolated from the marine-derived fungus 
Eutypella scoparia. This species, which has been reported from many and diverse 
environments ranging from soil in Antarctica
14
 to tropical forests of Australia
15
 and 
Thailand,
16
 was isolated here for the first time from a marine source. However, this is not 
surprising because other closely related fungi (e.g. Cytospora) mostly known in association 
with woody plants have been also reported from marine invertebrates, in accordance with the 
suggestion that fungi have the capability of adapting to harsh environment. 
 
3. Experimental 
 
3.1 General experimental procedure 
 
Silica-gel chromatography was performed using pre-coated Merck F254 plates and Merck 
Kieselgel 60 powder. Optical rotations were measured on a Jasco DIP 370 digital polarimeter. 
IR spectra were recorded on a Biorad FTS 155 FT-IR spectrophotometer. NMR experiments 
were recorded at ICB-NMR Service Centre. 1D and 2D NMR spectra were acquired in 
CD3OD ( values are reported referred to CD3OD at 3.34 ppm) on a Bruker DRX-600 
operating at 600 MHz, using an inverse TCI CryoProbe fitted with a gradient along the Z-
axis. 
13
C NMR were recorded on a Bruker DPX-300 operating at 300 MHz ( values are 
reported to CD3OD, 49.0 ppm) using a dual probe. High resolution ESIMS were performed 
on a Micromass Q-TOF Micro
TM
 coupled with a HPLC Waters Alliance 2695. The 
instrument was calibrated by using a PEG mixture from 200 to 1000 MW (resolution 
specification 5000 FWHM, deviation <5 ppm RMS in the presence of a known lock mass).  
 
3.2 Fungal material and fermentation 
 7 
Isolate ICB-OBX was recovered from the surface of pulmonate Onchidium sp. collected on 
the beach of the Hainan island (South China Sea), during december 2005. On the basis of ITS 
sequence data it was identified as E. scoparia by the Centraalbureau voor Schimmelcultures 
(CBS, Utrecht, the Netherlands). 
The fungus E. scoparia ICB-OBX was grown on malt extract agar (MEA) at 28°C for a 
week. After a week of cultivation the mycelial plugs were cut by a cork borer and inoculated 
into 500 mL Erlenmeyer flasks containg 500 mL of malt extract broth (MEB), prepared with 
artificial seawater. This fermentation was performed at 28° C, without shaking, for 30 days, 
in a total volume of 4L. 
 
3.3 Extraction and isolation 
After incubation the mycelium was removed from the culture broth by filtration. Then, the 
broth (4 L) was extracted with ethyl acetate four times (400 mL x 4). The resulting organic 
extract was evaporated under vacuum to give a brown oil (400 mg) and partitioned by column 
chromatography on silica gel using stepwise gradient elution from CHCl3 and increasing 
amounts of CH3OH to give nine fractions, two of which containing compounds 1-5. The less 
polar fraction was further purified on silica gel column (n-Hexane-EtOAc gradient) to obtain 
cyclo-(D)-Pro-(D)-Leu (4, 3.9 mg) and cyclo-(D)-Pro-(D)-Phe (5, 2.0 mg). The more polar 
fraction was purified on silica gel column (n-Hexane-EtOAc gradient) to give phenochalasin 
B (3, 28.3 mg) and cytosporin D (1, 5.1 mg) and cytosporin E (2, 9.0 mg), in order of 
polarity. 
 
Cytosporin D (1): pale yellow oil; []D –3.02 (c 0.5, CH3OH); IR (KBr, liquid film) 3426 
(br), 2928, 1792, 1507, 1248 cm
–1
; HRESIMS: found 361.1988 (361.1991 calculated for 
C19H30O5Na); 
1
H- and 
13
C-NMR in CD3OD see Table 1. 
 
Cytosporin E (2): pale yellow oil; []D + 59.9 (c 0.29, CH3OH); IR (KBr, liquid film) 3339 
(br), 2936, 1792, 1651, 1462, 1375, 1032 cm
–1
; HRESIMS: found 405.1883 (405.1889 
calculated for C20H30O7Na); 
1
H- and 
13
C-NMR data in CD3OD see Table 1.  
 8 
1
H- and 
13
C-NMR data in DMSO-d6 ( in ppm, J in Hz): 3.75 (H-3, m), 2.10 (H-4eq, dd, 
12.8, 5.7), 1.74 (H-4ax, t, 12.8), 4.70 (H-6, d, 8.0), 5.52 (H-7, d, 8.0), 4.08 (H-10, s), 1.13 
(H3-11, s), 1.06 (H3-12, s), 4.28 (H-13a, dd,12.7, 4.4), 3.92 (H-13b, dd, 12.7, 6.0), 6.46 (H-14, 
d, 15.8), 5.88, (H-15, m), 2.15 (H2-16, m), 1.45 (H2-17, m), 1.41 (H2-18, m), 1.30 (H2-19, m), 
0.88 (H3-20, t, 7.0), 4.84 (OH-3, d, 4.8), 4.70 (OH-13, br t, 5.3), 5.28 (OH-5, br s); 76.0 (C-2, 
C), 69.2 (C-3, CH), 41.3 (C-4, CH2), 67.0 (C-5, C), 79.3 (C-6, CH), 73.5 (C-7, CH), 136.5 
(C-8, C), 127.5 (C-9, C), 68.1 (C-10, CH), 16.3 (C-11, CH3 ), 28.0 (C-12, CH3), 58.5 (C-13, 
CH2), 125.0 (C-14, CH), 133.0 (C-15, CH), 34.0 (C-16, CH2), 29.5 (C-17, CH2), 29.0 (C-18, 
CH2), 22.0 (C-19, CH2), 14.8 (C-20, CH3), 155.0 (C-21, C). 
 
Cytosporin C (6): tentative assignment ( in ppm, CDCl3) of the reported carbon values
9
: 77.2 
(C-2), 74.3 (C-3), 35.5 (C-4), 57.8 (C-5), 62.4 (C-6), 55.8 (C-7), 157.7 (C-8), 129.9 (C-9), 
68.9 (C-10), 16.0 (C-11), 27.8 (C-12), 189.7 (C-13), 31.6 (C-14), 29.9 (C-15), 29.1 (C-16), 
22.3 (C-17), 13.9 (C-18). 
 
Compound 1a. 1 mg of cytosporin D (1) was dissolved in anhydrous CH2Cl2 (0.5 mL) with 
catalytic amount of DMAP and 10 L of acetic anhydride was added to this solution. The 
reaction was stirred overnight at room temperature. CH2Cl2 was removed in vacuo and the 
residue was worked as usual to afford pure 1a (0.7 mg); Rf 0.9 (CHCl3/CH3OH, 98:2); 
selected 
1
H-NMR signals:  6.00 (H-7),  4.85 (H-3),  4.85-4.70 (H2-13),  2.12 (3H, 
CH3CO-13),  2.06 (6H, CH3CO-3 and CH3CO-7). ESIMS: m/z 465 (M+H), 405 (M-60+H), 
345 (M-2x60+H), 285 (M-3x60+H). 
Compound 1b: 5.0 mg of compound 1 (0.015mM) was stirred in anhydrous CH2Cl2 (1 mL) 
catalytic amount of DMAP and 5.0 mg of 4,4’-dimethoxytrytil chloride (0.015mM, DMT) for 
2h at room temperature. CH2Cl2 was removed in vacuo and the reaction mixture was purified 
by chromatography in a Pasteur pipette (SiO2, CHCl3). 
1
H- and 
13
C-NMR data in CD3OD ( 
in ppm, J in Hz): 3.66 (H-3, dd, 12.8, 4.1), 2.24 (H-4ax, t, 12.8), 1.64 (H-4eq, dd, 12.8, 4.1), 
3.26 (H-6, br s), 4.63 (H-7, br s), 4.51 (H-10, br s), 1.29 (H3-11, s), 1.30 (H3-12, s), 3.66 (H-
13a, d, 10.8), 3.80 (H-13b, d, 10.8), 6.04 (H-14, m), 6.03 (H-15, m), 2.07 (H2-16, m), 1.35 
(H2-17, m), 1.40 (H2-18, m), 1.30 (H2-19, m), 0.93 (H3-20, t, 6.8), 6.84-7.52 (Ar-H, 13H), 
 9 
3.80 (OCH3, s, 6H); 77.9 (C-2, C), 73.9 (C-3, CH), 36.5 (C-4, CH2), 57.5 (C-5, C), 61.6 (C-6, 
CH), 65.1 (C-7, CH), 134.4 (C-8, C), 130.0 (C-9, C), 68.6 (C-10, CH), 16.4 (C-11, CH3 ), 
27.9 (C-12, CH3), 61.2 (C-13, CH2), 127.8 (C-14, CH), 135.3 (C-15, CH), 34.3 (C-16, CH2), 
30.7 (C-17, CH2), 32.4 (C-18, CH2), 23.0 (C-19, CH2), 14.4 (C-20, CH3), 55.7 (OCH3), 
114.0-158.0 (Ar). 
 
Compound 1c (S-MTPA-ester): the compound was prepared by treating 2 mg of 1b with 
0.005 mL of R-(-)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic amount of DMAP 
under stirring for 16 h at room temperature. The ester was purified by chromatography in a 
Pasteur pipette (SiO2, CHCl3). Selected 
1
H NMR values are in Table 2. 
 
Compound 1d (R-MTPA-ester): the compound was prepared by treating 2 mg of 1b with 
0.005 mL of S-(-)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic amount of DMAP 
under stirring for 16 h at room temperature. The ester was purified by chromatography in a 
Pasteur pipette (SiO2, CHCl3). Selected 
1
H NMR values are in Table 2. 
 
Compound 2a. 1 mg of cytosporin E (2) was dissolved in anhydrous CH2Cl2 (0.5 mL) with 
catalytic amount of DMAP and 10 L of acetic anhydride was added to this solution. The 
reaction was stirred overnight at room temperature. CH2Cl2 was removed in vacuo and the 
residue was worked as usual to afford pure 2a (0.9 mg), Rf 0.5 (CHCl3/CH3OH, 95:5); 
selected 
1
H-NMR signals (CD3OD,  in ppm):  5.25 (H-3),  4.95-4.82 (H2-13),  2.08 and 
2.10 (6H, CH3CO-3 and CH3CO-13). ESIMS: m/z 489 (M+Na), 407 (M-60+H).  
1
H- and 
13
C-NMR assignments in DMSO-d6 ( in ppm, J in Hz): 5.03 (H-3, dd, 11.8, 5.7), 
2.25 (H-4eq, dd, 11.8, 5.7), 1.84 (H-4ax, t, 11.8), 4.78 (H-6, d, 7.5), 5.60 (H-7, d, 7.5), 4.00 
(H-10, br s), 1.23 (H3-11, s), 1.02 (H3-12, s), 4.82 (H-13a, d, 13.5), 4.70 (H-13b, d, 13.5), 
6.45 (H-14, d, 15.8), 6.02, (H-15, m,), 2.18 (H2-16, m), 1.40 (H2-17, m), 1.22 (H2-18, m), 
1.30 (H2-19, m), 0.88 (H3-20, t, 6.6), 5.60 (OH-5, s), 2.03 (COCH3-3, s), 2.01 (COCH3-13, s); 
75.0 (C-2, C), 72.3 (C-3, CH), 37.5 (C-4, CH2), 67.0 (C-5, C), 79.0 (C-6, CH), 74.3 (C-7, 
CH), 130.0 (C-8, C), 132.0 (C-9, C), 69.2 (C-10, CH), 16.5 (C-11, CH3), 27.7 (C-12, CH3), 
61.0 (C-13, CH2), 124.0 (C-14, CH), 135.5 (C-15, CH), 32.9 (C-16, CH2), 28.2 (C-17, CH2), 
 10 
30.2 (C-18, CH2), 21.9 (C-19, CH2), 14.1 (C-20, CH3), 154.2 (C-21, C), 170.0 (COCH3-3 and 
COCH3-13, C), 21.5 (COCH3-3 and COCH3-13, C).  
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